We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ERCC1 Targeted Trial (ET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00801736
Recruitment Status : Terminated (The antibody used did not appear prognostic/predictive based on interim results.)
First Posted : December 3, 2008
Last Update Posted : December 10, 2013
Eli Lilly and Company
Cancer Research UK
Information provided by (Responsible Party):
University College, London

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2013
Study Completion Date : No date given